You have 9 free searches left this month | to do more
Showing 1 - 25 of
448 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
Active, not recruiting
  • Acute Myeloid Leukemia
  • Azacitidine and Venetoclax
  • Aurora, Colorado
    University of Colorado Denver
2021-10-12
Oct 12, 2021
U
CC-486 and Venetoclax for Acute Myeloid Leukemia
Recruiting
  • AML
  • Aurora, Colorado
  • +1 more
2022-04-04
Apr 4, 2022
N
Pharmacokinetics of Venetoclax in Patients With Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-10-27
Oct 27, 2021
N
Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic Leukemia
Recruiting
  • Chronic Lymphocytic Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-10-27
Oct 27, 2021
T
Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults
Enrolling by invitation
  • Myelodysplastic/Myeloproliferative Neoplasms
  • Adult
  • venetoclax combined with azacitidine
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
2022-03-07
Mar 7, 2022
N
A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.
Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
2022-03-29
Mar 29, 2022
D
Safe Accelerated Venetoclax Escalation in CLL
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-09-08
Sep 8, 2021
S
REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
Recruiting
  • CLL/SLL
  • Brussels, Belgium
  • +17 more
2022-03-22
Mar 22, 2022
D
Ibrutinib + Venetoclax in Untreated WM
Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
2022-04-01
Apr 1, 2022
A
Expanded Access to Venetoclax
Available
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Venetoclax
  • (no location specified)
2022-03-28
Mar 28, 2022
M
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Venetoclax
  • +5 more
  • (no location specified)
2022-03-30
Mar 30, 2022
U
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
2022-02-15
Feb 15, 2022
M
Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL
Not yet recruiting
  • CLL
  • (no location specified)
2022-02-08
Feb 8, 2022
C
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML
Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Venetoclax
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
2022-02-28
Feb 28, 2022
C
Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2022-02-08
Feb 8, 2022
U
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
Recruiting
  • Chronic Lymphocytic Leukemia
  • San Diego, California
    UCSD Koman Family Outpatient Pavilion
2021-11-24
Nov 24, 2021
L
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
2022-03-04
Mar 4, 2022
P
Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
Recruiting
  • Breast Neoplasm Female
  • Venetoclax
  • +2 more
  • Melbourne, Victoria, Australia
  • +2 more
2022-03-10
Mar 10, 2022
N
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Recruiting
  • Chronic Lymphocytic Leukemia
  • During Venetoclax
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
K
Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma - 2021
Terminated
  • Primary CNS Lymphoma
  • Stuttgart, Baden-Württemberg, Germany
    Klinikum Stuttgart
2022-01-18
Jan 18, 2022
J
Zanubrutinib + Venetoclax in CLL/SLL
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
2022-03-16
Mar 16, 2022
V
Venetoclax and Irinotecan in Relapsed/Refractory SCLC
Withdrawn
  • Relapsed Small Cell Lung Cancer
  • Refractory Small Cell Lung Carcinoma
  • Venetoclax 50 MG
  • +6 more
  • (no location specified)
2021-03-01
Mar 1, 2021
C
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Suspended
  • Leukemia
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2021-12-29
Dec 29, 2021
H
Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML
Recruiting
  • AML
  • Venetoclax 100 MG
  • +2 more
  • Monterrey, Nuevo LEON, Mexico
    Andres Gomez
2021-09-07
Sep 7, 2021
K
Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance - 2021
Withdrawn
  • Chronic Lymphocytic Leukemia
  • Loss of Chromosome 17p
  • (no location specified)
2021-10-29
Oct 29, 2021